Literature DB >> 18685869

TGF-beta1 gene polymorphisms and primary vesicoureteral reflux in childhood.

Magdalena Kowalewska-Pietrzak1, Izabela Klich, Wojciech Mlynarski.   

Abstract

The aim of this study was to assess the association between the transforming growth factor-beta1 (TGF-beta1) gene polymorphisms rs1800469 (commonly known as T-509C) and rs1982073 (commonly known as Leu (10)-->Pro) and primary vesicoureteral reflux (VUR) and renal scarring. Using a case-control approach, we examined 121 children with primary VUR and 169 controls. Genotyping of the TGF-beta1 gene polymorphisms was performed by restriction fragment length polymorphism (RFLP) analysis. The (99m)Tc-DMSA- or (99m)Tc-unitiol-single photon emission computed tomography method was used to evaluate renal scars in 84 of 121 VUR children. Statistical analysis revealed differences in rs1800469 genotype frequencies between VUR patients and controls (p = 0.0021). Our data demonstrate that individuals homozygous for the TT genotype are at risk of primary VUR [odds ratio (95% confidence interval) = 2.7 (1.46-5.08)]. Distribution of the rs1982073 polymorphism was similar in VUR children and controls. In terms of renal scarring, patients were stratified into non-scar and scar subgroups, and no differences in the genotype frequencies of either polymorphism was found. Previous reports have shown that the TT genotype of the rs1800469 polymorphism is a risk factor for renal scarring in primary VUR, and the results of our study suggest that this same polymorphism is associated with susceptibility to this congenital uropathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685869     DOI: 10.1007/s00467-008-0927-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  32 in total

1.  Cortical scintigraphy in the evaluation of renal defects in children with vesico-ureteral reflux--optimization of the procedure and study interpretation.

Authors:  Mariusz Gadzicki; Małgorzata Bińkiewicz; Ewa Młodkowska; Małgorzata Knapska; Magdalena Kowalewska-Pietrzak; Jacek Kuśmierek
Journal:  Nucl Med Rev Cent East Eur       Date:  2004

2.  Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms.

Authors:  Riddhish Shah; Brad Rahaman; Carolyn Katovich Hurley; Phillip E Posch
Journal:  Hum Genet       Date:  2005-12-14       Impact factor: 4.132

Review 3.  Report on management of renal failure in Europe, XXV, 1994. The child-adult interface. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association.

Authors:  O Mehls; S Rigden; J H Ehrich; F Berthoux; E H Jones; F Valderrábano
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

4.  Association of transforming growth factor-beta1 gene polymorphism with reflux nephropathy.

Authors:  Valeria Solari; Dwight Owen; Prem Puri
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

5.  In vitro studies on the roles of transforming growth factor-beta 1 in rat metanephric development.

Authors:  A T Clark; R J Young; J F Bertram
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

6.  99mTechnetium-unithiol complex, a new pharmaceutical for kidney scintigraphy.

Authors:  M Ogiński; M Rembelska
Journal:  Nuklearmedizin       Date:  1976-12       Impact factor: 1.379

7.  Five-year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children.

Authors:  J M Smellie; T Tamminen-Möbius; H Olbing; I Claesson; I Wikstad; U Jodal; U Seppänen
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

8.  Potential biological role of transforming growth factor-beta1 in human congenital kidney malformations.

Authors:  S P Yang; A S Woolf; H T Yuan; R J Scott; R A Risdon; M J O'Hare; P J Winyard
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

9.  Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux.

Authors:  Guey-Jen Lee-Chen; Kuo-Pao Liu; Yi-Chun Lai; Huei-Shiuan Juang; Shu-Yi Huang; Ching-Yuang Lin
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

10.  TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants.

Authors:  Daniel P K Ng; James H Warram; Andrzej S Krolewski
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  5 in total

Review 1.  Genetic susceptibility to renal scar formation after urinary tract infection: a systematic review and meta-analysis of candidate gene polymorphisms.

Authors:  Marco Zaffanello; Stefano Tardivo; Luigi Cataldi; Vassilios Fanos; Paolo Biban; Giovanni Malerba
Journal:  Pediatr Nephrol       Date:  2010-11-30       Impact factor: 3.714

Review 2.  Genetics of innate immunity and UTI susceptibility.

Authors:  Bryndís Ragnarsdóttir; Nataliya Lutay; Jenny Grönberg-Hernandez; Bela Köves; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2011-07-12       Impact factor: 14.432

Review 3.  Genetics of vesicoureteral reflux.

Authors:  Prem Puri; Jan-Hendrik Gosemann; John Darlow; David E Barton
Journal:  Nat Rev Urol       Date:  2011-08-23       Impact factor: 14.432

4.  Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies.

Authors:  Mariana A Vasconcelos; Maria Candida F Bouzada; Katia D Silveira; Leticia R Moura; Fabiana F Santos; Juliana M Oliveira; Flavia F Carvalho; Mauro M Teixeira; Ana Cristina Simões E Silva; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2011-02-18       Impact factor: 3.714

5.  Estimation of the relationship between the polymorphisms of selected genes: ACE, AGTR1, TGFβ1 and GNB3 with the occurrence of primary vesicoureteral reflux.

Authors:  Marcin Życzkowski; Joanna Żywiec; Krzysztof Nowakowski; Andrzej Paradysz; Władyslaw Grzeszczak; Janusz Gumprecht
Journal:  Int Urol Nephrol       Date:  2016-12-17       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.